TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T60182	Glucagon receptor	B2L6BC	3-[(1H-Benzimidazole-2-ylthio)acetyl]benzoic acid	Investigative	10519171	C16H12N2O3S	312.3	C1=CC=C2C(=C1)NC(=N2)SCC(=O)C3=CC(=CC=C3)C(=O)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	B38NPW	1-(3,4-Dihydroxyphenyl)-2-(1H-imidazole-2-ylthio)ethanone	Investigative	10729333	C11H10N2O3S	250.28	C1=CC(=C(C=C1C(=O)CSC2=NC=CN2)O)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	B5SPL2	2-(1H-Benzimidazol-2-ylsulfanyl)-1-(3,4-dimethoxyphenyl)ethanone	Investigative	825433	C17H16N2O3S	328.4	COC1=C(C=C(C=C1)C(=O)CSC2=NC3=CC=CC=C3N2)OC	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	B8GUF7	1-(3,4-Dihydroxyphenyl)-2-(benzoxazole-2-ylthio)ethanone	Investigative	4450383	C15H11NO4S	301.3	C1=CC=C2C(=C1)N=C(O2)SCC(=O)C3=CC(=C(C=C3)O)O	Ki = 250000 nM	Non binder
T60182	Glucagon receptor	B8OW2I	4-[2-(1H-Benzoimidazol-2-ylsulfanyl)-1-hydroxy-ethyl]-2-chloro-phenol	Investigative	10829563	C15H13ClN2O2S	320.8	C1=CC=C2C(=C1)NC(=N2)SCC(C3=CC(=C(C=C3)O)Cl)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	B9OP7B	2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-chloro-4-hydroxy-phenyl)-ethanone O-methyl-oxime	Investigative	135503833	C16H14ClN3O2S	347.8	CO/N=C(/CSC1=NC2=CC=CC=C2N1)\\C3=CC(=C(C=C3)O)Cl	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BA72CY	1-(3-Hydroxyphenyl)-2-(1H-benzimidazole-2-ylthio)ethanone	Investigative	10613052	C15H12N2O2S	284.3	C1=CC=C2C(=C1)NC(=N2)SCC(=O)C3=CC(=CC=C3)O	Ki = 380000 nM	Non binder
T60182	Glucagon receptor	BCKD18	1-(3,4-Dihydroxyphenyl)-4-(1H-benzimidazole-2-ylthio)-1-butanone	Investigative	10640008	C17H16N2O3S	328.4	C1=CC=C2C(=C1)NC(=N2)SCCCC(=O)C3=CC(=C(C=C3)O)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BI8H5R	2-(1H-Benzimidazol-2-ylsulfanyl)-1-phenylethanone	Investigative	416615	C15H12N2OS	268.3	C1=CC=C(C=C1)C(=O)CSC2=NC3=CC=CC=C3N2	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BMWE02	1-(3,4-Dichlorophenyl)-2-(1H-benzimidazole-2-ylthio)ethanone	Investigative	747420	C15H10Cl2N2OS	337.2	C1=CC=C2C(=C1)NC(=N2)SCC(=O)C3=CC(=C(C=C3)Cl)Cl	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BN24OF	1-(3,4-Dihydroxyphenyl)-2-(1-methyl-1H-benzimidazole-2-ylthio)ethanone	Investigative	10638990	C16H14N2O3S	314.4	CN1C2=CC=CC=C2N=C1SCC(=O)C3=CC(=C(C=C3)O)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BO0D5W	4-[(1H-Benzimidazole-2-ylthio)acetyl]benzoic acid	Investigative	10757473	C16H12N2O3S	312.3	C1=CC=C2C(=C1)NC(=N2)SCC(=O)C3=CC=C(C=C3)C(=O)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BOL8G6	2-(1H-Benzimidazol-2-ylsulfanyl)-1-(3,5-dihydroxyphenyl)ethanone	Investigative	71456188	C15H12N2O3S	300.3	C1=CC=C2C(=C1)NC(=N2)SCC(=O)C3=CC(=CC(=C3)O)O	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BS08ZM	2-(1H-Benzoimidazol-2-ylsulfanyl)-1-(3-chloro-4-hydroxy-phenyl)-ethanone O-benzyl-oxime	Investigative	135503932	C22H18ClN3O2S	423.9	C1=CC=C(C=C1)CO/N=C(/CSC2=NC3=CC=CC=C3N2)\\C4=CC(=C(C=C4)O)Cl	Ki > 500000 nM	Non binder
T60182	Glucagon receptor	BV4L3Q	1-(3,4-Dihydroxyphenyl)-2-(1H-benzimidazol-2-ylthio)-1-pentanone	Investigative	10854791	C18H18N2O3S	342.4	CCCC(C(=O)C1=CC(=C(C=C1)O)O)SC2=NC3=CC=CC=C3N2	Ki > 500000 nM	Non binder